Cardiovascular Systems (NASDAQ:CSII) Trading Down 5.7%
Cardiovascular Systems (NASDAQ:CSII) Trading Down 5.7%
Cardiovascular Systems, Inc. (NASDAQ:CSII – Get Rating)'s share price dropped 5.7% during mid-day trading on Friday . The stock traded as low as $13.28 and last traded at $13.29. Approximately 1,185 shares were traded during trading, a decline of 100% from the average daily volume of 283,807 shares. The stock had previously closed at $14.10.
纳斯达克(代码：CSII-GET Rating)周五午盘交易中，心血管系统公司股价下跌5.7%。该股最低跌至13.28美元，最新报13.29美元。该股当日成交量约为1,185股，较平均日成交量283,807股下降一倍。此前该股收盘报14.10美元。
Wall Street Analysts Forecast Growth
华尔街分析师预测经济增长
CSII has been the topic of several research reports. StockNews.com initiated coverage on shares of Cardiovascular Systems in a research report on Wednesday, October 12th. They set a "hold" rating on the stock. Lake Street Capital initiated coverage on shares of Cardiovascular Systems in a research report on Wednesday, December 14th. They set a "buy" rating and a $25.00 price objective on the stock. Finally, Barclays assumed coverage on shares of Cardiovascular Systems in a report on Wednesday. They issued an "equal weight" rating and a $15.00 target price on the stock. One equities research analyst has rated the stock with a sell rating, two have issued a hold rating and two have given a buy rating to the company. According to MarketBeat.com, the stock has an average rating of "Hold" and an average price target of $20.00.
CSII一直是几份研究报告的主题。StockNews.com在10月12日星期三的一份研究报告中启动了对心血管系统股票的报道。他们对该股设定了“持有”评级。Lake Street Capital在12月14日星期三的一份研究报告中启动了对心血管系统股票的报道。他们为该股设定了“买入”评级和25.00美元的目标价。最后，巴克莱在周三的一份报告中对心血管系统的股票进行了报道。他们对该股给予了“同等权重”的评级和15.00美元的目标价。一位股票研究分析师对该股的评级为卖出，两位分析师给出了持有评级，两位分析师给出了该公司的买入评级。根据MarketBeat.com的数据，该股的平均评级为持有，平均目标价为20.00美元。
Cardiovascular Systems Trading Up 0.2 %
心血管系统公司股价上涨0.2%
The firm has a market cap of $557.84 million, a PE ratio of -13.32 and a beta of 0.86. The company's fifty day moving average price is $14.08 and its two-hundred day moving average price is $14.40. The company has a quick ratio of 5.20, a current ratio of 6.22 and a debt-to-equity ratio of 0.08.
该公司市值为5.5784亿美元，市盈率为-13.32，贝塔系数为0.86。该公司的50日移动均线价格为14.08美元，200日移动均线价格为14.40美元。该公司的速动比率为5.20，流动比率为6.22，债务权益比为0.08。
Institutional Trading of Cardiovascular Systems
心血管系统的制度性交易
A number of institutional investors have recently added to or reduced their stakes in the stock. Bank of New York Mellon Corp boosted its holdings in Cardiovascular Systems by 0.4% during the third quarter. Bank of New York Mellon Corp now owns 360,772 shares of the medical device company's stock worth $4,999,000 after buying an additional 1,595 shares in the last quarter. Teachers Retirement System of The State of Kentucky purchased a new stake in Cardiovascular Systems during the third quarter worth about $150,000. M&T Bank Corp boosted its holdings in Cardiovascular Systems by 16.7% during the third quarter. M&T Bank Corp now owns 46,606 shares of the medical device company's stock worth $647,000 after buying an additional 6,673 shares in the last quarter. Neuberger Berman Group LLC boosted its holdings in Cardiovascular Systems by 6.5% during the third quarter. Neuberger Berman Group LLC now owns 859,542 shares of the medical device company's stock worth $11,920,000 after buying an additional 52,815 shares in the last quarter. Finally, Jacobs Levy Equity Management Inc. raised its position in Cardiovascular Systems by 9.8% during the third quarter. Jacobs Levy Equity Management Inc. now owns 171,062 shares of the medical device company's stock worth $2,371,000 after acquiring an additional 15,261 shares during the last quarter. Hedge funds and other institutional investors own 86.61% of the company's stock.
一些机构投资者最近增持或减持了该股。纽约梅隆银行(Bank Of New York Mellon Corp)第三季度将其在心血管系统公司的持股增加了0.4%。纽约梅隆银行(Bank Of New York Mellon Corp)目前持有360,772股这家医疗设备公司的股票，价值4,999,000美元，此前该公司在上个季度又购买了1,595股。肯塔基州教师退休系统在第三季度购买了心血管系统公司的新股份，价值约15万美元。M&T Bank Corp在第三季度增持了16.7%的心血管系统股份。M&T银行(M&T Bank Corp)目前持有46,606股这家医疗设备公司的股票，价值647,000美元，此前该公司在上个季度又购买了6,673股。Neuberger Berman Group LLC在第三季度将其在心血管系统公司的持股增加了6.5%。Neuberger Berman Group LLC现在持有这家医疗设备公司859,542股股票，价值11,920,000美元，上个季度又购买了52,815股。最后，雅各布斯·利维股票管理公司在第三季度将其在心血管系统公司的地位提高了9.8%。雅各布斯·利维股权管理公司(Jacobs Levy Equity Management Inc.)目前持有这家医疗设备公司171,062股股票，价值2,371,000美元，此前该公司在上个季度增持了15,261股。对冲基金和其他机构投资者持有该公司86.61%的股票。
About Cardiovascular Systems
关于心血管系统
(Get Rating)
(获取评级)
Cardiovascular Systems, Inc, a medical technology company, develops and commercializes solutions to treat peripheral and coronary artery diseases in the United States and internationally. The company offers peripheral artery disease products comprising catheter-based platforms to treat various plaque types in above and below the knee, including calcified plaque, as well as address various limitations related with surgical, catheter, and pharmacological treatment alternatives; and peripheral support products.
心血管系统公司是一家医疗技术公司，在美国和国际上开发和销售治疗外周和冠状动脉疾病的解决方案。该公司提供外周动脉疾病产品，包括基于导管的平台，用于治疗膝盖以上和膝盖以下的各种斑块类型，包括钙化斑块，以及解决与手术、导管和药物治疗替代方案相关的各种限制；以及外周支持产品。
See Also
另请参阅
- Get a free copy of the StockNews.com research report on Cardiovascular Systems (CSII)
- MarketBeat: Week in Review 12/19 – 12/23
- These Steelmakers Deserve A Place On Your 2023 Watch List
- Inflation Cools, Where Does The S&P 500 Go Now
- Cintas Beats Inflation With Operating Leverage
- Your Decision to Buy Palantir May Simply Be a Matter of Time
- 免费获取StockNews.com心血管系统研究报告(CSII)
- MarketBeat：回顾一周12/19-12/23
- 这些钢铁制造商理应在2023年观察名单上占有一席之地
- 通胀降温，标普500指数何去何从
- Cintas以经营杠杆击败通胀
- 你买下Palantir的决定可能只是个时间问题
Receive News & Ratings for Cardiovascular Systems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardiovascular Systems and related companies with MarketBeat.com's FREE daily email newsletter.
接受《每日心血管系统》新闻和评级-在下面输入您的电子邮件地址，通过MarketBeat.com的免费每日电子邮件时事通讯接收对心血管系统和相关公司的最新新闻和分析师评级的每日简要摘要。